The economics of bladder cancer: costs and considerations of caring for this disease.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Due to high recurrence rates, intensive surveillance strategies, and expensive treatment costs, the management of bladder cancer contributes significantly to medical costs.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Eur. Urol.

Title: European urology

ISSN (Electronic): 1873-7560

ISSN (Print): 0302-2838

Publication date (Electronic): Aug 2014

Volume: 66

Issue: 2

Affiliations

[1 ] Department of Urology, Division of Urologic Oncology, The University of Texas Health Science Center San Antonio, San Antonio, TX, USA.

[2 ] Department of Urology, Division of Health Services Research and Division of Urologic Oncology, University of Michigan, Ann Arbor, MI, USA.

[3 ] Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden.

[4 ] Department of Urology and Division of Medical Oncology, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY, USA.

[5 ] Department of Urology, Yale University, New Haven, CT, USA.

[6 ] Department of Urology, Klinik für Urologie, Tübingen, Germany.

[7 ] Department of Urology, University of Texas Southwestern, Dallas, TX, USA. Electronic address: yair.lotan@utsouthwestern.edu.

Article

Publisher Item ID: S0302-2838(14)00018-9

DOI: 10.1016/j.eururo.2014.01.006

PubMed ID: 24472711

SO-VID: f7a47c7d-cda0-48db-9cdf-11ce62edad80

History

Keywords: Bladder cancer,Charge,Cost,Cost effectiveness

Data availability:

Keywords: Bladder cancer, Charge, Cost, Cost effectiveness

Comments

Comment on this article

scite_

Cited by 176

See all cited by